Bilimsel Makale Arama | NeuralCipher AI

Kaynak kaydı

Phenotypic Characteristics in GBA-Associated Parkinson's Disease: A Study in a Greek Population.

Simitsi A, Koros C, Moraitou M, Papagiannakis N, Antonellou R, Bozi M, Angelopoulou E, Stamelou M, Michelakakis H, Stefanis L.

J Parkinsons Dis · 2018-01-01

DOI: 10.3233/jpd-171221PMID: 29480223

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Molecular mechanisms of α-synuclein and GBA1 in Parkinson's disease.

Stojkovska I, Krainc D, Mazzulli JR.

Cell Tissue Res · 2017-10-24

DOI: 10.1007/s00441-017-2704-yPMID: 29064079

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Dermal fibroblasts from patients with Parkinson's disease have normal GCase activity and autophagy compared to patients with PD and GBA mutations.

Collins LM, Drouin-Ouellet J, Kuan WL, Cox T, Barker RA.

F1000Res · 2017-09-26

DOI: 10.12688/f1000research.12090.2PMID: 29527290

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Lysosomal defects in ATP13A2 and GBA associated familial Parkinson's disease.

Sato S, Li Y, Hattori N.

J Neural Transm (Vienna) · 2017-09-11

DOI: 10.1007/s00702-017-1779-7PMID: 28894968

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Serum lipid alterations in GBA-associated Parkinson's disease.

Guedes LC, Chan RB, Gomes MA, Conceição VA, Machado RB, Soares T, Xu Y, Gaspar P, Carriço JA, Alcalay RN, Ferreira JJ, Outeiro TF, Miltenberger-Miltenyi G.

Parkinsonism Relat Disord · 2017-09-01

DOI: 10.1016/j.parkreldis.2017.08.026PMID: 28890071

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease.

Taguchi YV, Liu J, Ruan J, Pacheco J, Zhang X, Abbasi J, Keutzer J, Mistry PK, Chandra SS.

J Neurosci · 2017-08-28

DOI: 10.1523/jneurosci.1525-17.2017PMID: 28847804

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Clinical profiles associated with LRRK2 and GBA mutations in Brazilians with Parkinson's disease.

da Silva CP, de M Abreu G, Cabello Acero PH, Campos M, Pereira JS, de A Ramos SR, Nascimento CM, Voigt DD, Rosso AL, Araujo Leite MA, Vasconcellos LFR, Nicaretta DH, Della Coletta MV, da Silva DJ, Gonçalves AP, Dos Santos JM, Calassara V, Valença DCT, de M Martins CJ, Santos-Rebouças CB, Pimentel MMG.

J Neurol Sci · 2017-08-24

DOI: 10.1016/j.jns.2017.08.3249PMID: 28991672

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal.

Berge-Seidl V, Pihlstrøm L, Maple-Grødem J, Forsgren L, Linder J, Larsen JP, Tysnes OB, Toft M.

Neurosci Lett · 2017-08-19

DOI: 10.1016/j.neulet.2017.08.040PMID: 28830825

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

GBA mutations in Parkinson disease: earlier death but similar neuropathological features.

Adler CH, Beach TG, Shill HA, Caviness JN, Driver-Dunckley E, Sabbagh MN, Patel A, Sue LI, Serrano G, Jacobson SA, Davis K, Belden CM, Dugger BN, Paciga SA, Winslow AR, Hirst WD, Hentz JG.

Eur J Neurol · 2017-08-17

DOI: 10.1111/ene.13395PMID: 28834018

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

N370S-GBA1 mutation causes lysosomal cholesterol accumulation in Parkinson's disease.

García-Sanz P, Orgaz L, Bueno-Gil G, Espadas I, Rodríguez-Traver E, Kulisevsky J, Gutierrez A, Dávila JC, González-Polo RA, Fuentes JM, Mir P, Vicario C, Moratalla R.

Mov Disord · 2017-08-05

DOI: 10.1002/mds.27119PMID: 28779532

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Dual-Task Performance in GBA Parkinson's Disease.

Srulijes K, Brockmann K, Ogbamicael S, Hobert MA, Hauser AK, Schulte C, Fritzen J, Schwenk M, Gasser T, Berg D, Maetzler W.

Parkinsons Dis · 2017-07-27

DOI: 10.1155/2017/8582740PMID: 28819579

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

A molecular analysis of the <i>GBA</i> gene in Caucasian South Africans with Parkinson's disease.

Barkhuizen M, Anderson DG, van der Westhuizen FH, Grobler AF.

Mol Genet Genomic Med · 2017-02-08

DOI: 10.1002/mgg3.267PMID: 28361101

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

404 makale bulundu

Phenotypic Characteristics in GBA-Associated Parkinson's Disease: A Study in a Greek Population.

Molecular mechanisms of α-synuclein and GBA1 in Parkinson's disease.

Dermal fibroblasts from patients with Parkinson's disease have normal GCase activity and autophagy compared to patients with PD and GBA mutations.

Lysosomal defects in ATP13A2 and GBA associated familial Parkinson's disease.

Serum lipid alterations in GBA-associated Parkinson's disease.

Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease.

Clinical profiles associated with LRRK2 and GBA mutations in Brazilians with Parkinson's disease.

The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal.

GBA mutations in Parkinson disease: earlier death but similar neuropathological features.

N370S-GBA1 mutation causes lysosomal cholesterol accumulation in Parkinson's disease.

Dual-Task Performance in GBA Parkinson's Disease.

A molecular analysis of the <i>GBA</i> gene in Caucasian South Africans with Parkinson's disease.

Filtreler